Suppr超能文献

N(1)-甲基烟酰胺的肾清除率:肝硬化肝功能障碍严重程度的敏感标志物。

Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis.

作者信息

Orlando R, Floreani M, Napoli E, Padrini R, Palatini P

机构信息

Department of Medical and Surgical Sciences, University of Padova, Italy.

出版信息

Nephron. 2000 Jan;84(1):32-9. doi: 10.1159/000045536.

Abstract

BACKGROUND/AIMS: Data have appeared suggesting that an impairment of renal tubular secretion is present in liver cirrhosis, even in the absence of a clinically evident renal dysfunction. To address this question, we evaluated the renal clearance of N(1)-methylnicotinamide (NMN), a marker of the renal secretory function, in healthy subjects and patients with liver cirrhosis of increasing severity, but with a normal glomerular filtration rate.

METHODS

The renal clearances of endogenous NMN, inulin, and creatinine were measured in 14 normal subjects and in two groups of age-matched cirrhotic patients (10 Child A and 10 Child C). In 6 subjects, 2 per group, the concentration dependence of the NMN clearance was also studied, following an oral nicotinamide load.

RESULTS

Contrary to expectations, the renal NMN clearance increased in cirrhotic patients, in relation to the severity of liver disease (r = 0.83 with Pugh's score; p < 0.001). The NMN-to-inulin clearance ratio increased from a control value of 2.2 +/- (SD) 0.4 to 3.1 +/- 0.2 and 5.2 +/- 0.9 in Child A and Child C cirrhotics, respectively (p < 0.001 for all comparisons), indicating that NMN was completely cleared from plasma in the latter patients. Consistently, the analysis of the concentration dependence of the renal NMN clearance revealed the presence of a carrier-mediated reabsorption which apparently was no longer operating in the decompensated patients. Discriminant analysis showed that renal NMN clearance, and NMN-to-creatinine and NMN-to-inulin clearance ratios could all distinguish between the three study groups, with sensitivities and specificities equal or greater than 90%.

CONCLUSIONS

Contrary to previous proposals, NMN is not a probe of general validity for renal tubular secretion. In particular, due to an imbalance between secretion and reabsorption, its renal clearance in liver cirrhosis cannot be used to determine the degree of tubular secretion of which an individual is capable. However, renal NMN clearance appears to be a very sensitive marker of the severity of liver dysfunction in cirrhosis. The potentialities of this renal parameter as a diagnostic and prognostic test in liver cirrhosis deserve further study.

摘要

背景/目的:已有数据表明,即使在无临床明显肾功能不全的情况下,肝硬化患者也存在肾小管分泌功能受损。为解决这一问题,我们评估了健康受试者以及病情严重程度不同但肾小球滤过率正常的肝硬化患者中,作为肾分泌功能标志物的N(1)-甲基烟酰胺(NMN)的肾清除率。

方法

测量了14名正常受试者以及两组年龄匹配的肝硬化患者(10名Child A级和10名Child C级)的内源性NMN、菊粉和肌酐的肾清除率。在每组2名共6名受试者中,口服烟酰胺负荷后,还研究了NMN清除率的浓度依赖性。

结果

与预期相反,肝硬化患者的肾NMN清除率随肝病严重程度增加而升高(与Pugh评分的r = 0.83;p < 0.001)。Child A级和Child C级肝硬化患者中,NMN与菊粉清除率之比分别从对照组的2.2±(标准差)0.4增至3.1±0.2和5.2±0.9(所有比较p < 0.001),表明在后者患者中NMN已从血浆中完全清除。同样,对肾NMN清除率浓度依赖性的分析显示存在载体介导的重吸收,而在失代偿患者中这种重吸收显然不再起作用。判别分析表明,肾NMN清除率以及NMN与肌酐、NMN与菊粉清除率之比均可区分三个研究组,敏感性和特异性均等于或大于90%。

结论

与先前观点相反,NMN并非肾小管分泌的通用有效检测指标。特别是,由于分泌与重吸收失衡,其在肝硬化中的肾清除率不能用于确定个体的肾小管分泌能力。然而,肾NMN清除率似乎是肝硬化患者肝功能障碍严重程度的非常敏感的标志物。该肾参数作为肝硬化诊断和预后检测指标的潜力值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验